Typhoid Vaccine
Epidemiology plays role in introducing typhoid fever vaccines in Asia
Published in Vaccine Weekly, February 16th, 2005
According to recent research published in the Journal of Health Population and Nutrition, "Despite the availability of at least two licensed typhoid fever vaccines - injectable sub-unit Vi polysaccharide vaccine and live, oral Ty21a vaccine - for the last decade, these vaccines have not been widely introduced in public health programs in countries endemic for typhoid fever. The goal of the multidisciplinary DOMI (Diseases of the Most Impoverished) typhoid fever program is to generate policy-relevant data to support public decision-making regarding the introduction of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2005-02-16)
More Articles from Vaccine Weekly
- Anthrax Vaccine
Protein fusion enhances immunogenicity of anthrax protective antigen - Cancer Vaccine
Soluble tumor-associated antigens have antitumor effect on mammary tumors - Cancer Vaccines
Reports advance knowledge in cancer vaccines research - HIV/AIDS Vaccine
Glycoprotein-deficient rabies virus expressing SHIV envelope suppressed SHIV - Meningitis Vaccine
Immunogenicity of meningitis oligosaccharide-protein vaccine described - Vaccine Adjuvant
Liposome-encapsulated CpG ODN is adjuvant for inducing type 1 innate immunity - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
